» Articles » PMID: 38249528

Neuronal Dysfunction and Gene Modulation by Non-coding RNA in Parkinson's Disease and Synucleinopathies

Overview
Specialty Cell Biology
Date 2024 Jan 22
PMID 38249528
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last few decades, emerging evidence suggests that non-coding RNAs (ncRNAs) including long-non-coding RNA (lncRNA), microRNA (miRNA) and circular-RNA (circRNA) contribute to the molecular events underlying progressive neuronal degeneration, and a plethora of ncRNAs have been identified significantly misregulated in many neurodegenerative diseases, including Parkinson's disease and synucleinopathy. Although a direct link between neuropathology and causative candidates has not been clearly established in many cases, the contribution of ncRNAs to the molecular processes leading to cellular dysfunction observed in neurodegenerative diseases has been addressed, suggesting that they may play a role in the pathophysiology of these diseases. Aim of the present Review is to overview and discuss recent literature focused on the role of RNA-based mechanisms involved in different aspects of neuronal pathology in Parkinson's disease and synucleinopathy models.

Citing Articles

Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.

Secondulfo C, Mazzeo F, Pastorino G, Vicidomini A, Meccariello R, Operto F Int J Mol Sci. 2024; 25(17).

PMID: 39273354 PMC: 11394805. DOI: 10.3390/ijms25179407.


Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.

Xu K, Li Y, Zhou Y, Zhang Y, Shi Y, Zhang C Front Cell Neurosci. 2024; 18:1429977.

PMID: 39131043 PMC: 11310010. DOI: 10.3389/fncel.2024.1429977.

References
1.
Devi L, Raghavendran V, Prabhu B, Avadhani N, Anandatheerthavarada H . Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008; 283(14):9089-100. PMC: 2431021. DOI: 10.1074/jbc.M710012200. View

2.
Lin H, Li Z, Chen C, Luo X, Xiao J, Dong D . Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel. PLoS One. 2011; 6(5):e20362. PMC: 3105031. DOI: 10.1371/journal.pone.0020362. View

3.
Dong Y, Han L, Xu Z . Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease. Mol Med. 2018; 24(1):61. PMC: 6263543. DOI: 10.1186/s10020-018-0059-9. View

4.
Rey F, Pandini C, Messa L, Launi R, Barzaghini B, Zangaglia R . α-Synuclein antisense transcript SNCA-AS1 regulates synapses- and aging-related genes suggesting its implication in Parkinson's disease. Aging Cell. 2021; 20(12):e13504. PMC: 8672788. DOI: 10.1111/acel.13504. View

5.
Heyer M, Pani A, Smeyne R, Kenny P, Feng G . Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci. 2012; 32(32):10887-94. PMC: 3752074. DOI: 10.1523/JNEUROSCI.1732-12.2012. View